User:Mr. Ibrahem/Vandetanib

Vandetanib, sold under the brand name Caprelsa, is an anti-cancer medication used to treat a type of thyroid cancer, specifically medullary thyroid cancer. It increases the amount of time before the disease worsens. It is taken by mouth.

Common side effects include acne, high blood pressure, headache, low calcium, low blood sugar, and diarrhea. Other side effects include QT prolongation, sun sensitivity, hair loss, swelling, and corneal deposits. Use during pregnancy or breastfeeding may harm the baby. It works as a kinase inhibitor, mainly of the vascular endothelial growth factor receptor 2 (VEGFR2) and the epidermal growth factor receptor (EGFR).

Vandetanib was approved for medical use in the United States in 2011. In the United Kingdom it costs the NHS £5,000 per month as of 2020. In the United States this amount costs about 16,000 USD as of 2021; while in Canada it cost about 5,900 CAD per month as of 2017.